Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shorthouse

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Transplantation Proceedings|December 1, 1996
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2W W Cao, P N Kao, Y Aoki, et al.
Transplantation Proceedings|February 1, 1995
Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cellsR E Morris, W Cao, X Huang, et al.
Neurogastroenterology and Motility|May 22, 2016
Interplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowelY Yu, D M Daly, I J Adam, et al.
Transplantation Proceedings|February 1, 1993
A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allograftsE K Nakakura, S M McCabe, B Zheng, et al.
Transplantation|February 1, 1993
Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletionE K Nakakura, S M McCabe, B Zheng, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Transplantation Proceedings|December 1, 1996
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2W W Cao, P N Kao, Y Aoki, et al.
Transplantation Proceedings|February 1, 1995
Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cellsR E Morris, W Cao, X Huang, et al.
Neurogastroenterology and Motility|May 22, 2016
Interplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowelY Yu, D M Daly, I J Adam, et al.
Transplantation Proceedings|February 1, 1993
A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allograftsE K Nakakura, S M McCabe, B Zheng, et al.
Transplantation|February 1, 1993
Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletionE K Nakakura, S M McCabe, B Zheng, et al.
Pageof 2